Lumos Pharma (LUMO) Financials

$4.34

$0.00 (0.00%)

As on 13-Dec-2024 09:30EDT

Market cap

$38 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

7.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	2.21	2.05	1.52	0.23	0.17	0.94
Cost of Revenue	0.02	0.04	0.05	--	--	0.04
Gross Profit	2.18	2.05	1.52	0.23	0.17	0.90
Operating Expenses	38.51	38.67	33.56	31.58	26.47	46.07
Operating Profit (EBIT)	-36.33	-36.61	-32.04	-31.35	-26.30	-45.13
Other Income	--	--	--	--	6.67	2.21
Profit before Tax	-34.92	-34.06	-31.08	-31.07	-19.64	-42.98
Provision for Tax	0.68	-0.03	-0.01	-0.64	-13.97	0.01
Profit after Tax (Net Income)	-34.92	-34.03	-31.06	-30.43	-5.66	-42.99
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-31.06	-30.43	-6.31	-42.99

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	4.91	27.31	59.58	88.98	116.57	78.88
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.04	6.30	6.00	6.21	6.00	6.08
Current Liabilities	6.51	7.03	6.71	5.13	6.46	11.83
Total Liabilities	23.97	40.64	72.29	100.31	129.03	96.79

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.19	0.60	0.28	0.64	0.58	2.37
Current Assets	17.27	40.04	72.01	99.68	128.45	94.42
Total Assets	23.97	40.64	72.29	100.31	129.03	96.79
Total Debt*	0.17	0.59	0.23	0.56	0.32	1.23
Net Current Assets	10.77	33.01	65.30	94.55	121.99	82.59

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-31.10	-26.62	-29.65	-23.00	-30.21
Cash Flow from Investing Activities	--	--	-11.36	25.97	116.65	0.08
Cash from Financing Activities	--	-0.58	-0.82	-0.19	0.08	-0.06
Net Cash Inflow / Outflow	--	--	--	--	93.73	-30.19

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-4.28	-4.20	-3.76	-3.64	-0.68	-10.37
Cash EPS ($)	--	-4.19	-3.75	-3.62	-0.61	-10.10
Adjusted Book Value ($)	--	3.37	7.21	10.65	14.06	19.02
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.84	-3.22	-3.55	-2.77	-7.29
Free Cash Flow per Share ($)	--	-3.84	-3.22	-3.55	-2.78	-7.29

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-77.61	-41.60	-29.48	-5.75	-44.01
ROE (%)	-312.41	-78.34	-41.82	-29.61	-5.79	-44.31
ROA (%)	-89.72	-60.27	-35.99	-26.54	-5.02	-37.76
EBIT Margin (%)	-1,302.26	-1,785.18	-2,103.74	-13,629.13	-15,656.55	-4,822.01
Net Margin (%)	-1,583.49	-1,659.39	-2,039.53	-13,230.43	-82.85	-1,367.77
Cash Profit Margin (%)	-0.08	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	26.94	0.35	5.62	0.37	-0.82	-0.22
EBIT Growth (%)	19.03	-14.28	-2.21	-19.18	41.72	26.80
Net Profit Growth (%)	-10.63	-9.57	-2.08	-437.35	86.83	19.79
EPS Growth (%)	-10.67	-0.12	-0.03	-4.33	0.93	0.20
Book Value Growth (%)	-86.73	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.76	-0.96	-1.90	-52.29	-0.24
Price / Book Value	7.64	0.94	0.50	0.65	2.54	0.13
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.39	0.27	1.17	1.17	-7.69	1.84
Close Price ($)	3.87	3.18	3.61	6.93	35.71	22.77
High Price ($)	4.55	4.55	10.27	35.45	36.72	32.40
Low Price ($)	1.37	2.63	2.95	6.80	6.74	10.17
Market Cap ($ Cr)	37.54	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.02	0.00	0.01	0.00	0.02
Short term debt to equity ratio	0.03	0.02	0.01	0.01	0.01	0.01
Current Ratio	2.66	5.69	10.73	19.43	19.88	7.98
Quick Ratio	2.66	--	--	19.46	--	--
Interest Coverage	-24.34	--	-36.66	-64.77	-3.63	-902.68

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	7.89	10.24	14.64	55.65	15,633.33	88.03
Asset Turnover	0.06	0.04	0.02	0.00	0.00	0.01
Receivable days	--	38.56	42.09	20,955.82	29,446.11	316.47
Inventory Days	--	--	-954.12	--	--	--
Payable days	--	4,835.41	3,305.89	--	--	5,083.89
Cash Conversion Cycle	--	--	-4,217.92	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.